(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.25%) $924.40
(0.34%) $0.935
(0.60%) $11.02
(0.21%) $0.801
(0.00%) $92.17
Live Chart Being Loaded With Signals
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products...
Stats | |
---|---|
本日の出来高 | 292.00 |
平均出来高 | 141.00 |
時価総額 | 3.20B |
EPS | $28.08 ( 2023-09-30 ) |
Last Dividend | $0.185 ( 2021-09-28 ) |
Next Dividend | $0 ( N/A ) |
P/E | 13.47 |
ATR14 | $0 (0.00%) |
MediPal Holdings 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
MediPal Holdings 財務諸表
Annual | 2023 |
収益: | $3 360.01B |
総利益: | $212.12B (6.31 %) |
EPS: | $184.82 |
FY | 2023 |
収益: | $3 360.01B |
総利益: | $212.12B (6.31 %) |
EPS: | $184.82 |
FY | 2022 |
収益: | $3 290.92B |
総利益: | $205.11B (6.23 %) |
EPS: | $140.13 |
FY | 2021 |
収益: | $3 211.17B |
総利益: | $214.26B (6.67 %) |
EPS: | $113.96 |
Financial Reports:
No articles found.
MediPal Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.191 | 2021-03-29 |
Last Dividend | $0.185 | 2021-09-28 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | $0.376 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.71 | -- |
Div. Sustainability Score | 3.56 | |
Div.Growth Potential Score | 1.062 | |
Div. Directional Score | 2.31 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OVCHY | Ex Dividend Junior | 2023-08-15 | Annually | 0 | 0.00% | |
DURYY | Ex Dividend Junior | 2023-05-15 | Annually | 0 | 0.00% | |
TTNDY | Ex Dividend Knight | 2023-08-28 | Semi-Annually | 0 | 0.00% | |
JMSB | Ex Dividend Junior | 2023-06-26 | Annually | 0 | 0.00% | |
BORT | Ex Dividend Knight | 2023-08-10 | Quarterly | 0 | 0.00% | |
RGPCF | Ex Dividend Junior | 2023-09-01 | Semi-Annually | 0 | 0.00% | |
FBPI | Ex Dividend Knight | 2023-08-30 | Quarterly | 0 | 0.00% | |
VTKLY | Ex Dividend Knight | 2023-07-20 | Semi-Annually | 0 | 0.00% | |
LNVGY | Ex Dividend Knight | 2023-07-26 | Annually | 0 | 0.00% | |
CKHGY | Ex Dividend Knight | 2023-05-11 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0106 | 1.500 | 9.79 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0199 | 1.200 | 9.34 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0646 | 1.500 | -0.393 | -0.590 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.198 | 0.800 | 9.01 | 7.21 | [1 - 3] |
quickRatioTTM | 0.928 | 0.800 | 9.25 | 7.40 | [0.8 - 2.5] |
cashRatioTTM | 0.194 | 1.500 | -0.0355 | -0.0533 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 2 643.15 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 0 | 2.00 | 0 | 0 | [0 - 30] |
freeCashFlowPerShareTTM | 0 | 2.00 | 0 | 0 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.0647 | 1.000 | -2.25 | -2.25 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0151 | 1.000 | -1.699 | -1.699 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 1.872 | 0.800 | 0.854 | 0.683 | [0.5 - 2] |
Total Score | 3.56 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 13.64 | 1.000 | 8.72 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0646 | 2.50 | -0.253 | -0.590 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0 | 2.00 | 0 | 0 | [0 - 30] |
dividendYielPercentageTTM | 0.00505 | 1.500 | 9.87 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0 | 2.00 | 0 | 0 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.00270 | 1.500 | -3.32 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0 | 1.000 | -2.50 | 0 | [0.1 - 0.5] |
Total Score | 1.062 |
MediPal Holdings
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。